Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster Vaccination with Heterologous H5N1 Vaccine in Healthy Young Adults
NCT00530660Phase 2Completed
- Sponsor
- Resilience Government Services
- Start
- Sep 2007
- Primary completion
- May 2008
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of inactivated influenza vaccine (vero cell-derived) in Influenza A H5N1 (H5N1), sponsored by Resilience Government Services. Started Sep 2007; status: completed.
02
Drugs
inactivated influenza vaccine (vero cell-derived)
03
Conditions
Influenza A H5N1 (H5N1)
Beyond the preview
Go deeper on NCT00530660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00530660.